Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in Atopic Dermatitis (Eczema)

ClinicalTrials.gov ID: NCT00076375

Public ClinicalTrials.gov record NCT00076375. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 12:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Two Concentrations of Nanocrystalline Silver Cream (NPI) Applied Twice Daily in Adults With Mild to Moderate Atopic Dermatitis

Study identification

NCT ID
NCT00076375
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Nucryst Pharmaceuticals
Industry
Enrollment
180 participants

Conditions and interventions

Interventions

  • Nanocrystalline silver cream (NPI) Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2003
Primary completion
Not listed
Completion
Mar 31, 2004
Last update posted
Jun 23, 2005

2003 – 2004

United States locations

U.S. sites
19
U.S. states
15
U.S. cities
18
Facility City State ZIP Site status
Radiant Research Birmingham Alabama 35209
Medical Affliated Research Centers, Inc. Huntsville Alabama 35801
National Jewish Medical & Research Center Denver Colorado 80206
nTouch Research Washington D.C. District of Columbia 20037
Radiant Research West Palm Beach Florida 33407
Radiant Research Boise Idaho 83704
Radiant Research Overland Park Kansas 66215
Radiant Research St Louis Missouri 63141
Sadick Dermatology & Aesthetic Surgery New York New York 10021
Mount Sinai School of Medicine New York New York 10029
Clinical Research of Winston-Salem, Inc. Winston-Salem North Carolina 27103
University Hospitals of Cleveland Cleveland Ohio 44106
Radiant Research Columbus Ohio 43212
Oregon Health & Science University Portland Oregon 97239
Radiant Research Philadelphia Pennsylvania 19115
National Allergy, Asthma & Urticaria Centers of Charleston, P.A. Charleston South Carolina 29407
Radiant Research Greer South Carolina 29605
ACE Research Specialists, Inc. Nashville Tennessee 37203
Radiant Research Lakewood Washington 98499

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00076375, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2005 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00076375 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →